Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer
Open Access
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (27) , 24467-24475
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activityBMC Biotechnology, 2009
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cellsBiochemical Journal, 2007
- Binding Site Structure of One LRP–RAP Complex:Implications for a Common Ligand–Receptor Binding MotifJournal of Molecular Biology, 2006
- Plasminogen Activator Inhibitor-2 is Highly Tolerant to P8 Residue Substitution—Implications for Serpin Mechanistic Model and Prediction of nsSNP ActivitiesJournal of Molecular Biology, 2005
- EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR, UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND PLASMINOGEN ACTIVATOR INHIBITORS IN PATIENTS WITH RENAL CELL CARCINOMA: CORRELATION WITH TUMOR ASSOCIATED MACROPHAGE AND PROGNOSISJournal of Urology, 2005
- Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell linesExperimental Cell Research, 2004
- Urokinase Plasminogen Activator SystemClinical Orthopaedics and Related Research, 2003
- The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I ComplexesJournal of Biological Chemistry, 1995
- Plasminogen‐activator inhibitor type 2 (PAI‐2) is a spontaneously polymerising SERPINEuropean Journal of Biochemistry, 1993